New in MMWR: Smoking Cessation, Counterfeit Oxycodone Pills, and more

["Morbidity and Mortality Weekly Report \(MMWR\) \(CDC\)" <no-reply@xxxxxxxxxxxxxxxxxxxx>]

This Week in MMWR: Vol. 73, July 25, 2024

July 25, 2024

In this Issue

Smoking cessation, adults Counterfeit oxycodone pills— Western U.S. hospital	Mother-to-child transmission of hepatitis B — The Americas Influenza A(H5N1) — Michigan

WEEKLY REPORT

Adult Smoking Cessation

In 2022, most of the 28.8 million U.S. adults who reported cigarette smoking wanted to quit, half tried to quit, but fewer than 10% were successful.

• Suspected Counterfeit M-30 Oxycodone Pill Exposures and Acute Withdrawals Reported from a Single Hospital

  Among patients with exposure to suspected counterfeit M-30 pills, more than 3 in 10 were intubated; nearly 1 in 5 involving ingestion received a naloxone drip infusion.

• Progress Toward Elimination of Mother-to-Child Transmission of Hepatitis B Virus

  Substantial progress has been made in the World Health Organization Region of the Americas in reducing the prevalence of chronic hepatitis B virus infection in children through vaccination.

• Notes from the Field: Health Monitoring, Testing, and Case Identification Among Persons Exposed to Influenza A(H5N1)

  Active symptom monitoring and testing of exposed workers led to detection of two avian influenza infections among dairy workers.

READ THE WEEKLY REPORTS

PDF of this issue (link)

CONTINUING EDUCATION

A new, free CME from MMWR and Medscape discusses the latest ACIP recommendations for the tick-borne encephalitis vaccine.

EARN FREE CE

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  |